Although mean SP PSA levels were not significantly altered in PCa patients, a combination of all three markers further improved results with the multivariate model, indicating potential utility in determining and integrating all three in a panel of biomarkers. The gene discussed is KLK3; the disease is posterior cortical atrophy.